Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 12, 2009, Pages 5623-5632

  González Sarrías, Antonio ^a   Azorín Ortuño, María ^a   Yáñez Gascón, María Josefa ^a   Tomás Barberán, Francisco A ^a   García Conesa, María Teresa ^a   Espín, Juan Carlos ^a  

^a CSIC   (Spain)

Author keywords

Caco 2; Cancer; Colon mucosa; CYP1A1; Glucuronosyltransferases; Pomegranate; Sulfotransferases; Xenobiotic metabolism

Indexed keywords

3,8 DIHYDROXY 6H DIBENZO(B,D)PYRAN 6 ONE; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; COUMARIN DERIVATIVE; CYTOCHROME P450 1A1; ELLAGIC ACID;

ANIMAL; ARTICLE; CELL STRAIN CACO 2; CHEMISTRY; COLON TUMOR; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; POMEGRANATE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CACO-2 CELLS; COLONIC NEOPLASMS; COUMARINS; CYTOCHROME P-450 CYP1A1; ELLAGIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PUNICACEAE; RATS; RATS, SPRAGUE-DAWLEY;

LYTHRACEAE; RATTUS;

EID: 67649214140     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf900725e     Document Type: Article

References (42)

1. Yu, S.; Kong, A. N. Targeting carcinogen metabolism by dietary cancer preventive compounds. Curr. Cancer Drug Targets 2007, 7, 416-424.
2. Shimada, T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenesis polycyclic aromatic hydrocarbons. Drug Metab. Pharmacokinet. 2006, 21, 257-276.
3. McKay, J. A.; Murray, G. I.; Weave, R. J.; Ewen, S. W.; Melvin, W. T.; Burke, M. D. Xenobiotic metabolizing enzyme expression in colonic neoplasia. Gut 1993, 34, 1234-1239.
4. Turkey, R. H.; Strassburg, C. P. Human UDP-glucuronosyltransferases: Metabolism, expression and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 581-616.
5. Kumarakulasingham, M.; Rooney, P. H.; Dundas, S. R.; Telfer, C.; Melvin, W. T.; Curran, S.; Murray, G. I. Cytochrome P450 profile of colorectal cancer: Identification of markers of prognosis. Clin. Cancer Res. 2005, 11, 3758-3765.
6. Sivaraman, L.; Leatham, M. P.; Yee, J.; Wilkens, L. R.; Lau, A. F.; Le Marchand, L. CYPlA1 genetic polymorphisms and in situ colorectal cancer. Cancer Res. 1994, 54, 3692-3695.
7. Conney, A. H. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: The seventh DeWitt S. Goodman lecture. Cancer Res. 2003, 63, 7005-7031.
8. Uno, S.; Dalton, T. P.; Derkenne, S.; Curran, C. P.; Miller, M. L.; Shertzer, H. C.; Nebert, D. W. Oral exposure to dibenzo[a,l]pyrene in the mouse: Detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol. 2004, 65, 1225-1237.
9. Moon, Y. J.; Wang, X.; Morris, M. E. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 2006, 20, 187-210.
10. Kale, A.; Gawande, S.; Kotwal, S. Cancer phytotherapeutics: Role for flavonoids at the cellular level. Phytother. Res. 2008, 22, 567-577.
11. Pohl, C.; Will, F.; Dietrich, H.; Schrenk, D. Cytochrome P450 1A1 in Caco-2 cells: Modulation by apple juice extract and certain apple polyphenols. J. Agric. Food Chem. 2006, 54, 10262-10268.
12. Hidaka, M.; Okumura, M.; Fujita, K.-L; Ogikubo, T.; Yamasaki, K.; Iwakiri, T.; Setoguchi, N.; Arimori, K. Effects of pomegranate juice on human cytochrome P450 3A (CYP3A) and carbamazepine pharmacokinetics in rats. Drug Metab. Dispos. 2005, 33, 644-648.
13. Nagata, M.; Hidaka, M.; Sekiya, H.; Kawano, Y.; Yamasaki, K. M.; Arimori, K. Effects of pomegranate juice on human cytochrome P4502C9 and tolbutamide pharne pharmacokinetics in rats. Drug Metab. Dispos. 2007, 35, 302-305.
14. Faria, A.; Monteiro, R.; Azevedo, I.; Calhau, C. Pomegranate juice effects on cytochrome P450S expression: In vivo studies. J. Med. Food 2007, 70, 643-649.
15. Cerdá, B.; Periago, P.; Espin, J. C.; Tomás- Barberán, F. A. Identification of urolithin A as a metabolite produced by human colon microflora from ellagic acid and related compounds. J. Agric. Food Chem. 2005, 53, 5571-5579.
16. Espin, J. C.; González-Barrio, R.; Cerdá, B.; López-Bote, C.; Rey, A. I.; Tomás-Barberán, F. A. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J. Agric. Food Chem. 2007, 55, 10476-10485.
17. Seeram, N. P.; Adams, L. S.; Henning, S. M.; Niu, Y.; Zhang, Y.; Nair, M. G.; Heber, D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem. 2005, 16, 360-367.
18. Larrosa, M.; Tomás-Barberán, F. A.; Espin, J. C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J. Nutr. Biochem. 2006, 17, 611-625.
19. Päivärinta, E.; Pajari, A. M.; Törrönen, R.; Mutanen, M. Ellagic acid and natural sources of ellagitannins as possible chemopreventive agents against intestinal tumorigenesis in the Min mouse. Nutr. Cancer 2006, 1, 79-83.
20. González-Sarrias, A.; Espin, J. C.; Tomás-Barberán, F. A.; Garcia-Conesa, M. T. Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to acid ellagic and its metabolites, urolithins. Mol. Nutr. Food Res. 2009, [Epub ahead of print] PMID: 19437480.
21. Cerda, B.; Llorach, R.; Cerón, J. J.; Espin, J. C.; Tomás-Barberán, F. A. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur. J. Nutr. 1003, 42, 18-28.
22. Larrosa, M.; Tomás-Barberán, F. A.; Espin, J. C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J. Nutr. Biochem. 2006, 17, 611-625.
23. Ciolino, H. P.; Bass, S. E.; MacDonald, C. J.; Cheng, R. Y. S.; Yeh, G. C. Sulindac and its metabolites induce carcinogen metabolizing enzymes in human colon cancer cells. Int. J. Cancer 2008, 122, 990-998.
24. Cerdá, B.; Espin, J. C.; Parra, S.; Martínez, P.; Tomás-Barberán, F. A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6ff-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur. J. Nutr. 2004, 43, 205-220.
25. Sergent, T.; Dupont, I.; Jassogne, C.; Ribonnet, L.; van der Heiden, E.; Scippo, M. L.; Muller, M.; McAlister, D.; Pussemier, L.; Larondelle, Y.; Schneider, Y. J. CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-Comparison with other conazole pesticides. Toxicol. Lett. 2009, 184, 159-168.
26. Kahle, K.; Kraus, M.; Scheppach, W.; Ackermann, M.; Ridder, F.; Richling, E. Studies on apple and blueberry fruit constituents: Do the polyphenols reach the colon after ingestion?. Mol. Nutr. Food Res. 2006, 50, 418-423.
27. Chun, Y.-J.; Kim, S. Discovery of cytochrome P450 1B1 inhibitors as new promising anti-cancer agents. Med. Res. Rev. 2003, 23, 657-668.
28. Seliskar, M.; Rozman, D. Mammalian cytochromes P450-Importance of tissue specificity. Biochim. Biophys. Acta 2007, 1770, 458-466.
29. Kállay, E.; Adlercreutz, H.; Farhan, H.; Lechner, D.; Bajna, E.; Gerdenitsch, W.; Campbell, M.; Cross, H. S. Phytoestrogens regulate vitamin D metabolism in the mouse colon: Relevance for colon tumor prevention and therapy. J. Nutr. 2002, 132, 3490S-3493S.
30. Martinez, C.; García-Marín, E.; Pizarro, R. M.; García-Gamito, F. J.; Agúndez, J. A. G. Expression of paclitaxel-inactiving CYP3A activity in human colorectal cancer: Implications for drug therapy. Br. J. Cancer 2002, 87, 681-686.
31. Bock, K. W.; Eckle, T.; Ouzzine, M.; Fournel-Gigleux, S. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem. Pharmacol. 2000, 59, 467-470.
32. Galijatovic, A.; Otake, Y.; Walle, K.; Walle, T. Induction of UDPglucuronosyltransferase UGT1A1 by the flavonoid Chrysin in Caco2 cells-Potential role in carcinogen bio-inactivation. Pharm. Res. 2001, 18, 374-379.
33. Starlard-Davenport, A.; Lyn-Cook, B.; Radominska-Pandya, A. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids 2008, 73, 138-147.
34. Boersma, M. G.; van der Woude, H.; Bogaards, J.; Boeren, S.; Vervoort, J.; Cnubben, N. H. P.; van Iersel, M. L. P. S.; van Bladeren, P. J.; Rietjens, I. M. C. M. Regioselectivity of phase II metabolism of Luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 2002, 15, 662-670.
35. Basu, N. K.; Kubota, S.; Meselhy, M. R.; Ciotti, M.; Chowdhury, B.; Hartori, M.; Owens, I. S. Gastrointestinal-distributed UDPglucuronosyltransferase IAlO, which metabolizes estrogens and nonsteroidal antiflammatory drugs, depends upon phosphorylation. J. Biol. Chem. 2004, 279, 28320-28329.
36. Pai, T. G.; Suiko, M.; Sakakibara, Y.; Liu, M.-C. Sulfation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases. Biochem. Biophys. Res. Commun. 2001, 255, 1175-1179.
37. Eaton, E. A.; Walle, U. K.; Lewis, A. J.; Hudson, T.; Wilson, A. A.; Walle, T. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potencial role in drug metabolism and chemoprevention. Drug Metab. Dispos. 1996, 24, 232-237.
38. Saruwatari, A.; Okamura, S.; Nakajima, Y.; Narukava, Y.; Takeda, T.; Tamura, H. Pomegranate juice inhibits sulfoconjugation in Caco2 human colon carcinoma cells. J. Med. Food 2008, 11, 623-628.
39. Larrosa, M.; González-Sarrias, A.; García-Conesa, M. T.; Tomás-Barberán, F. A.; Espin, J. C. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J. Agric. Food Chem. 2006, 54, 1611-1620.
40. Nishihashi, H.; Kanno, Y.; Tomuro, K.; Nakahama, T.; Inouye, Y. Primary structure and organ-specific expression of the rat aryl hydrocarbon receptor repressor gene. Biol. Pharm. Bull. 2006, 29, 640-647.
41. Kim, H.; Yoon, Y. J.; Shon, J. H.; Chan, I. J.; Shin, J. G.; Liu, K. H. Inhibitory effects of fruit juices on CYP3A activity. Drug Metab. Dispos. 2006, 34, 521-523.
42. Farkas, D.; Oleson, L. E.; Zhao, Y. L.; Harmatz, J. S.; Zinny, M. A.; Court, M. H.; Greenblatt, D. J. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: Comparison with grapefruit juice. J. Clin. Pharm. 2007, 47, 286-294.